TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35164772

Group type: COMPARATOR
Intervention: Core implementation strategies
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Enhanced implementation strategies
Number of subjects: 177
Study: 33724305

Group type: EXPERIMENTAL
Intervention: CPX-351
Number of subjects: 209

Group type: COMPARATOR
Intervention: Conventional 7+3 chemotherapy
Number of subjects: 209
Study: 35035849

Group type: EXPERIMENTAL
Intervention: Combined etomidate-ketamine anesthesia (etomidate 0.3 mg/kg + ketamine 0.5 mg/kg at 5 μg/kg/min)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined etomidate-ketamine anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ketamine anesthesia (control group)
Number of subjects: 100
Study: 33220095

Group type: EXPERIMENTAL
Intervention: 10 mg oral melatonin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 36474274

Group type: EXPERIMENTAL
Intervention: Primaquine (PQ) alongside standard artemisinin‐based combination therapy (ACT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard artemisinin‐based combination therapy (ACT) without primaquine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (with and without residual gametocytes)
Number of subjects: 100
Study: 32389224

Group type: EXPERIMENTAL
Intervention: Radiofrequency denervation combined with a standardized exercise program
Number of subjects: 681

Group type: COMPARATOR
Intervention: Standardized exercise program alone
Number of subjects: 681
Study: 34274921

Group type: EXPERIMENTAL
Intervention: Trimetazidine prolong 80 mg once daily
Number of subjects: 1670
Study: 36253032

Group type: EXPERIMENTAL
Intervention: YLB113 (50 mg subcutaneously every 2 weeks)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: YLB113
Number of subjects: 201
Study: 32080797

Group type: EXPERIMENTAL
Intervention: Bright Light (BL) therapy for 45 minutes for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dim Light (DL) therapy for 45 minutes for 4 weeks
Number of subjects: 18
Study: 32763649

Group type: EXPERIMENTAL
Intervention: 14-session parenting program delivered by local community members
Number of subjects: 552

Group type: COMPARATOR
Intervention: Control group received a brief informational workshop
Number of subjects: 552
Study: 35344046

Group type: EXPERIMENTAL
Intervention: Unilateral laminotomy with crossover
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Bilateral laminotomy
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Spinous process osteotomy
Number of subjects: 437
Study: 33060490

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with low tidal volume (LTV; 6-8 mL/kg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional tidal volume (CTV; 10-12 mL/kg)
Number of subjects: 82
Study: 32610511

Group type: EXPERIMENTAL
Intervention: Open Kinetic Chain Exercise (OKCE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Closed Kinetic Chain Exercise (CKCE)
Number of subjects: 26
Study: 35435086

Group type: EXPERIMENTAL
Intervention: 7 g of boiled walnut taken daily as snacks
Number of subjects: 45
Study: 33373480

Group type: EXPERIMENTAL
Intervention: brodalumab 210 mg Q2W
Number of subjects: 62

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 62
Study: 36082590

Group type: EXPERIMENTAL
Intervention: Tralokinumab
Number of subjects: 2285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2285
Study: 32438817

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 0
Study: 33314496

Group type: EXPERIMENTAL
Intervention: Sleep-restriction therapy (SRT)
Number of subjects: 18
Study: 35971080

Group type: EXPERIMENTAL
Intervention: Trachway® flexible stylet
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 108

Group type: COMPARATOR
Intervention: Flexible fiberoptic bronchoscopy
Number of subjects: 108
Study: 33472269

Group type: EXPERIMENTAL
Intervention: Prethrombectomy blood pressure management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-recanalization blood pressure management
Number of subjects: 0
Study: 35105176

Group type: EXPERIMENTAL
Intervention: Antibiotic-Eluting Envelope (AEE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34220999

Group type: EXPERIMENTAL
Intervention: Proposed machine learning-based network IDS using SMOTE and Extremely Randomized Trees Classifier
Number of subjects: 0
Study: 36239611

Group type: EXPERIMENTAL
Intervention: Cabozantinib with nivolumab and ipilimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0
Study: 34563178

Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 0
Study: 34655181

Group type: EXPERIMENTAL
Intervention: Landiolol (10 μg/kg/min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Esmolol (50 μg/kg/min)
Number of subjects: 16
Study: 33723649

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (maintaining telephone contacts and providing educational materials)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no telehealth intervention)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 33460319

Group type: EXPERIMENTAL
Intervention: 10 Hz tACS
Number of subjects: 33

Group type: COMPARATOR
Intervention: 20 Hz tACS
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 33
Study: 33432829

Group type: EXPERIMENTAL
Intervention: Soy protein isolate (19.2 g/day for 18 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Casein-based placebo
Number of subjects: 0
Study: 32660762

Group type: EXPERIMENTAL
Intervention: Eyhance EDOF monofocal IOL
Number of subjects: 30

Group type: COMPARATOR
Intervention: TECNIS 1‐piece IOL
Number of subjects: 30
Study: 35060070

Group type: EXPERIMENTAL
Intervention: Undergraduate experiential learning course
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Participation in translational research team meetings and events
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mentorship activities including graduate student theses and supplementary projects
Number of subjects: 56
Study: 33211212

Group type: EXPERIMENTAL
Intervention: Once-weekly teriparatide (56.5 µg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Once-weekly alendronate (35 mg)
Number of subjects: 180
Study: 32012080

Group type: EXPERIMENTAL
Intervention: Video-based education intervention
Number of subjects: 310

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 310
Study: 35978374

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) prior to speech-language therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) concurrent with speech-language therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) following speech-language therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham stimulation (speech-language therapy only)
Number of subjects: 48
Study: 33539554

Group type: EXPERIMENTAL
Intervention: Group-based exercise intervention
Number of subjects: 213

Group type: COMPARATOR
Intervention: Support group
Number of subjects: 213
Study: 32323640

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (12 weeks, 3 days/week, 60 min/session)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Center-based exercise program (12 weeks, 3 days/week, 60 min/session)
Number of subjects: 31
Study: 34930614

Group type: EXPERIMENTAL
Intervention: Ischemic postconditioning (iPOST) in addition to primary percutaneous coronary intervention (PCI) without thrombectomy
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Conventional primary percutaneous coronary intervention (PCI) without thrombectomy
Number of subjects: 1234

Group type: EXPERIMENTAL
Intervention: Ischemic postconditioning (iPOST) in addition to primary percutaneous coronary intervention (PCI) with thrombectomy
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Conventional primary percutaneous coronary intervention (PCI) with thrombectomy
Number of subjects: 1234
Study: 34208742

Group type: EXPERIMENTAL
Intervention: Bis-Hexanoyl (R)-1,3-Butanediol (BH-BD) 12.5 g (Days 0–7) and 25 g (Days 7–28)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Bis-Hexanoyl (R)-1,3-Butanediol (BH-BD)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 34766787

Group type: EXPERIMENTAL
Intervention: Label (mental illness called schizophrenia)
Number of subjects: 1481

Group type: COMPARATOR
Intervention: No label condition
Number of subjects: 1481
Study: 33683337

Group type: EXPERIMENTAL
Intervention: Tandem Fluzone High-Dose vaccination (2 doses)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard-of-care vaccination (single-dose)
Number of subjects: 122
Study: 32859638

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs) with concurrent resistance mutation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs) without concurrent mutations
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs) with non-pathogenic, non-resistance co-mutation
Number of subjects: 42
Study: 35073496

Group type: EXPERIMENTAL
Intervention: Dual-focus soft contact lenses
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-vision soft contact lenses
Number of subjects: 24
Study: 34363216

Group type: EXPERIMENTAL
Intervention: Revascularization (PCI or CABG)
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1015
Study: 32552472

Group type: EXPERIMENTAL
Intervention: ABFM C-MTX regimen
Number of subjects: 299

Group type: COMPARATOR
Intervention: Nelarabine (for high-risk patients)
Number of subjects: 299
Study: 36266613

Group type: EXPERIMENTAL
Intervention: Topical timolol 0.5% (w/w) applied twice daily for 6 weeks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Topical timolol 0.5% (w/w)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo topical gel
Number of subjects: 64
Study: 34001053

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF) measured by the six-minute running/walking test
Number of subjects: 2418
Study: 32062677

Group type: EXPERIMENTAL
Intervention: Liberal postoperative activity instructions
Number of subjects: 146

Group type: COMPARATOR
Intervention: Restricted postoperative activity instructions
Number of subjects: 146
Study: 616673046

Group type: EXPERIMENTAL
Intervention: Combination of IR‐A and MEL
Number of subjects: 123

Group type: COMPARATOR
Intervention: IR‐A
Number of subjects: 123

Group type: COMPARATOR
Intervention: MEL
Number of subjects: 123
Study: 34038230

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Individual burden indicators and neighborhood crime density
Number of subjects: 200
Study: 34840756

Group type: EXPERIMENTAL
Intervention: Monopolar electrosurgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 20
Study: 33657083

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 190
Study: 32530518

Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus
Number of subjects: 130

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 36284454

Group type: EXPERIMENTAL
Intervention: Rectus sheath block (RSB) with fentanyl PCA
Number of subjects: 36

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) alone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nausea/vomiting score
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Additional analgesic consumption
Number of subjects: 36
Study: 33421456

Group type: EXPERIMENTAL
Intervention: Text messaging intervention (3 text messages per week for 6 months)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard dietary care (control group)
Number of subjects: 130
Study: 83020338

Group type: EXPERIMENTAL
Intervention: apomorphine (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: amantadine (200 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 35245844

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32321680

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HFRT)
Number of subjects: 5190
Study: 33687496

Group type: EXPERIMENTAL
Intervention: 17 Y chromosomal genetic markers
Number of subjects: 202
Study: 32299679

Group type: EXPERIMENTAL
Intervention: Ramipril therapy
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ramipril therapy (randomized arm)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ramipril therapy (open-label comparison)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ramipril therapy (combined analysis)
Number of subjects: 66
Study: 34801952

Group type: EXPERIMENTAL
Intervention: Self-paced walking
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fixed-paced walking
Number of subjects: 18
Study: 33287716

Group type: EXPERIMENTAL
Intervention: EDDIE program (hospital avoidance initiative)
Number of subjects: 96
Study: 35301512

Group type: EXPERIMENTAL
Intervention: Low-dose vedolizumab (100 or 150 mg for patients <30 kg; 200 or 300 mg for patients ≥30 kg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High-dose vedolizumab (100 or 150 mg for patients <30 kg; 200 or 300 mg for patients ≥30 kg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both low and high-dose vedolizumab
Number of subjects: 88
Study: 32357854

Group type: EXPERIMENTAL
Intervention: Power-free-chop technique (Group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Phaco-chop technique (Group 2)
Number of subjects: 60
Study: 34861036

Group type: EXPERIMENTAL
Intervention: Third BNT162b2 mRNA vaccine dose
Number of subjects: 172
Study: 34357348

Group type: EXPERIMENTAL
Intervention: MCI Gel
Number of subjects: 4

Group type: COMPARATOR
Intervention: MCI Drink
Number of subjects: 4

Group type: COMPARATOR
Intervention: Hom. Cheese
Number of subjects: 4

Group type: COMPARATOR
Intervention: Cheese
Number of subjects: 4
Study: 35997659

Group type: EXPERIMENTAL
Intervention: Cluster 1 (Moderate Frequency, Moderate Pain)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cluster 2 (Almost Daily, High Pain)
Number of subjects: 62
Study: 33951060

Group type: EXPERIMENTAL
Intervention: Isothermal loop‐mediated amplification (LAMP) assay using saliva samples
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard RT-qPCR tests
Number of subjects: 0
Study: 32220372

Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D for 12 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1000 IU/day vitamin D for 12 weeks
Number of subjects: 50
Study: 35460441

Group type: EXPERIMENTAL
Intervention: EMPOWER-SMS
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study: 34606123

Group type: EXPERIMENTAL
Intervention: Herbal remedies (polyherbal decoction every 8 hr and two herbal capsules every 12 hr) plus standard care for 7 days
Number of subjects: 358

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 358
Study: 32977683

Group type: EXPERIMENTAL
Intervention: Narrative format
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Didactic format
Number of subjects: 151

Group type: COMPARATOR
Intervention: No information control group
Number of subjects: 151
Study: 34427066

Group type: EXPERIMENTAL
Intervention: New mortality scoring system based on demographic factors and laboratory findings
Number of subjects: 1232
Study: 33064025

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for 2 weeks
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for 4 weeks
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for longer than 4 weeks
Number of subjects: 261
Study: 33494301

Group type: EXPERIMENTAL
Intervention: Basic obedience training class
Number of subjects: 41

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 41
Study: 32360596

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (200,000 IU initially, then 100,000 IU monthly)
Number of subjects: 5110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5110
Study: 35275023

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 28.8 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 27
Study: 33215265

Group type: EXPERIMENTAL
Intervention: Tongue-strengthening self-exercises (TSsE) using a tongue-strengthening self-exercise tool, 30 repetitions, 3 times a day, 5 days a week for 8 weeks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tongue-strengthening self-exercises (TSsE) using a tongue-strengthening self-exercise tool
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Adherence to TSsE
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 27
Study: 33083489

Group type: EXPERIMENTAL
Intervention: Curcumin gel with scaling and root planing (SRP) for 7 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 90
Study: 34034143

Group type: EXPERIMENTAL
Intervention: IN-MLV (n = 11): 2 mL of IN MLV vaccine containing BHV1, BRSV, and BPI3V (Inforce3®)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: SC-MLV (n = 10): 2 mL of MLV vaccine containing BHV1, BRSV, BPI3V, and BVDV1 & 2 (Bovi-Shield GOLD® 5)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both IN and SC booster vaccination
Number of subjects: 21
Study: 35562804

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 208

Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: High-risk group (total risk score of ≥ 6.5 points)
Number of subjects: 208
Study: 32248552

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33433264

Group type: EXPERIMENTAL
Intervention: Email plus phone coaching (coaching condition)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Email prompts alone (non‐coaching condition)
Number of subjects: 136
Study: 32250470

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg)
Number of subjects: 24
Study: 35325102

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 2245

Group type: EXPERIMENTAL
Intervention: Digoxin users with AFF
Number of subjects: 2245

Group type: EXPERIMENTAL
Intervention: Patients without AFF
Number of subjects: 2245

Group type: EXPERIMENTAL
Intervention: Patients not using digoxin
Number of subjects: 2245

Group type: EXPERIMENTAL
Intervention: Digoxin users not in AFF
Number of subjects: 2245
Study: 32331021

Group type: EXPERIMENTAL
Intervention: Cariprazine 3-12 mg/d (flexible dosing)
Number of subjects: 2472

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/d
Number of subjects: 2472

Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/d
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2472
Study: 35842109

Group type: EXPERIMENTAL
Intervention: Basic video describing CRC and screening (Arm 2)
Number of subjects: 5280

Group type: EXPERIMENTAL
Intervention: Informed choice video showing advantages and disadvantages of FIT, s-DNA FIT, and colonoscopy (Arm 3)
Number of subjects: 5280

Group type: COMPARATOR
Intervention: No video at all (Arm 1)
Number of subjects: 5280
Study: 34684474

Group type: EXPERIMENTAL
Intervention: DUET intervention (web-based lifestyle intervention for 6 months)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 56
Study: 34753334

Group type: EXPERIMENTAL
Intervention: small-group reading intervention with anxiety management instruction (RANX)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: small-group reading intervention with math fact practice (RMATH)
Number of subjects: 128

Group type: COMPARATOR
Intervention: business-as-usual (BAU)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: RANX
Number of subjects: 128
Study: 32815418

Group type: EXPERIMENTAL
Intervention: Ablation as an adjunct to cardiac surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no ablation)
Number of subjects: 0
Study: 35114511

Group type: EXPERIMENTAL
Intervention: Wearing the HNSE
Number of subjects: 14

Group type: COMPARATOR
Intervention: Not wearing the HNSE
Number of subjects: 14
Study: 33709997

Group type: EXPERIMENTAL
Intervention: SBIRT program with brief motivational intervention and referral to specialized treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group receiving two leaflets regarding alcohol use and study protocol
Number of subjects: 200
Study: 33725776

Group type: EXPERIMENTAL
Intervention: In-hospital physiotherapy (daily post-operative physiotherapy intervention including individualized mobilization, breathing exercises, ambulation with or without a walking aid)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no physiotherapy treatment)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: In-hospital physiotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 32051297

Group type: EXPERIMENTAL
Intervention: Cetuximab plus FOLFOX‐4
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFOX‐4
Number of subjects: 0
Study: 34714938

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (PGE1; 25 μg)
Number of subjects: 1580

Group type: COMPARATOR
Intervention: Slow-release dinoprostone (PGE2; 10 μg)
Number of subjects: 1580
Study: 34931602

Group type: EXPERIMENTAL
Intervention: lamotrigine
Number of subjects: 1510

Group type: COMPARATOR
Intervention: levetiracetam
Number of subjects: 1510

Group type: COMPARATOR
Intervention: zonisamide
Number of subjects: 1510

Group type: EXPERIMENTAL
Intervention: valproate
Number of subjects: 1510
Study: 33627245

Group type: EXPERIMENTAL
Intervention: MG1111
Number of subjects: 515

Group type: COMPARATOR
Intervention: VarivaxTM
Number of subjects: 515

Group type: COMPARATOR
Intervention: MG1111 and VarivaxTM
Number of subjects: 515